📰 Ashraf Radwan News
Ashraf Radwan News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ashraf Radwan. Real-time updates on events, politics, business and more.
August 30, 2023
Alvotech and Bioventure received the Egyptian Drug Authority's approval to produce and supply AVT02 (adalimumab), a biosimilar for Humira.
August 29, 2023
Approval of Adalimumab-EVA™ represents the second biosimilar approval under the strategic partnership between Alvotech and Bioventure Alvotech (NASDAQ:...
August 29, 2023
REYKJAVIK, Iceland and DUBAI, United Arab Emirates, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO) and Bioventure, a wholly owned subsidiary of GlobalOne Healthcare Holding LLC, today announced that the
February 2, 2023
RIYADH: Saudi-based AJA Pharma has signed a Memorandum of Understanding with UAE’s Bioventure FZ-LLC to license and supply new pharmaceutical products. According to a bourse filing, the new additional selected pharmaceutical products in the Middle East region are set to be used in the Saudi Export stand at the upcoming Arab Health Expedition 2023. Under the terms of the new
January 24, 2023
Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi Arabia - read this article along with other careers information, tips and advice on BioSpace
November 30, 2022
/PRNewswire/ -- Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH, a...
November 30, 2022
BERLIN, CAIRO and DUBAI, UAE, Nov. 30, 2022 /PRNewswire/ -- Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH
November 29, 2022
Download logoBioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH
November 29, 2022
 BERLIN, Germany, CAIRO, Egypt and DUBAI, United Arab Emirates, November 29, 2022 / B3C newswire / -- Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH, a Berlin-based pharmaceutical company, announced today the signing of a...
June 27, 2022
The newly rebranded Bioventure Healthcare plans to expand the production capacity of its manufacturing plant by introducing new products such as oral solid tablets, capsules and sachets lines by 2023.